Background Infective endocarditis (IE) after transcatheter pulmonary valve implantation
(TPVI) in dysfunctioning right ventricular outflow tract conduits has evoked growing …

Abstract Purpose of Review The past couple of decades have brought tremendous
advances to the field of pediatric and adult congenital heart disease (CHD). Percutaneous …

Objectives: This study provides the 3-year follow-up results of the COMPASSION
(Congenital Multicenter Trial of Pulmonic Valve Regurgitation Studying the SAPIEN …

Objectives: The aim of this study was to describe and analyze data from patients treated in
France with the Edwards SAPIEN transcatheter heart valve (Edwards Lifesciences LLC …

Background Patients with congenital or acquired heart defects affecting the pulmonary valve
and right ventricular outflow tract (RVOT) commonly require multiple surgical interventions …

Objective This single center study compared the risk of bacterial endocarditis (BE) after
surgical and percutaneous pulmonary valve implantation. Methods Between Jan 1st 2010 …

Tissue-engineered heart valves with self-repair and regeneration properties may overcome
the problem of long-term degeneration of currently used artificial prostheses. The aim of this …

Background Since FDA approval of the Melody valve, transcatheter pulmonary valve
replacement (TPVR) has been offered to an expanding population. Limited data exist …

Background Percutaneous pulmonary valve implantation (PPVI) is a routine treatment for
dysfunctional right ventricular outflow tract. Infective endocarditis (IE) is a major concern. Aim …

The field of pediatric and adult congenital cardiac catheterization has evolved rapidly in
recent years. This review will focus on some of the newer endovascular technological and …